Literature DB >> 17016032

Endocrine tumors of the ileum: factors correlated with survival.

Paola Tomassetti1, Davide Campana, Lydia Piscitelli, Riccardo Casadei, Francesca Nori, Emilio Brocchi, Donatella Santini, Raffaele Pezzilli, Roberto Corinaldesi.   

Abstract

AIM: To evaluate the most important factors correlated with survival in patients with endocrine tumors of the ileum, both at the time of diagnosis and during the follow-up period.
METHODS: Fifty-nine patients with ileal endocrine tumors diagnosed in our institution between 1990 and 2004 were studied.
RESULTS: The study included 36 men (61%) and 23 women (39%). The median age of the patients at the time of diagnosis was 61.4 (range 18-83) years. The median follow-up period was 71.9 (range 5-287) months. Forty patients (67.8%) were still alive at the end of the study; the median survival time was 172 months, and the 5-year survival rate was 78.9%. By univariate analysis, the survival rate was significantly related to female sex (p = 0.024) and flushing alone (p = 0.028) and associated with diarrhea at diagnosis (p = 0.015), weight loss at diagnosis (p = 0.038), Ki-67 level (p = 0.025), stage of disease at diagnosis (p = 0.012), presence of liver metastases at follow-up (p = 0.005), presence of diffuse metastases at diagnosis (p = 0.005) and at follow-up (p = 0.007), and type of surgical approach (overall: p = 0.018; not operated vs. radical surgery: p = 0.008; not operated vs. palliative surgery: p = 0.045). Using multivariate analysis, only female gender (p = 0.012) and the presence of liver metastases at follow-up (p = 0.004) were significantly related to survival.
CONCLUSION: In the present study, female gender and the appearance of liver metastases at follow-up seem to be the main conditions which determine the poor prognosis of patients with ileal endocrine tumors.

Entities:  

Mesh:

Year:  2006        PMID: 17016032     DOI: 10.1159/000096053

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  13 in total

1.  TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; A Couvelard; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

2.  Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.

Authors:  Olov Norlén; Peter Stålberg; Kjell Öberg; John Eriksson; Jakob Hedberg; Ola Hessman; Eva Tiensuu Janson; Per Hellman; Göran Åkerström
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

3.  Role of Staging in Patients with Small Intestinal Neuroendocrine Tumours.

Authors:  Ashley Kieran Clift; Omar Faiz; Adil Al-Nahhas; Andreas Bockisch; Marc Olaf Liedke; Erik Schloericke; Harpreet Wasan; John Martin; Paul Ziprin; Krishna Moorthy; Andrea Frilling
Journal:  J Gastrointest Surg       Date:  2015-09-22       Impact factor: 3.452

4.  Treatment of colorectal carcinoids: A new paradigm.

Authors:  Tsuyoshi Konishi; Toshiaki Watanabe; Hirokazu Nagawa; Masatoshi Oya; Masashi Ueno; Hiroya Kuroyanagi; Yoshiya Fujimoto; Takashi Akiyoshi; Toshiharu Yamaguchi; Tetsuichiro Muto
Journal:  World J Gastrointest Surg       Date:  2010-05-27

5.  A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience.

Authors:  Claudio Ricci; Davide Campana; Chiara Casadei; Carlo Ingaldi; Valentina Ambrosini; Nico Pagano; Donatella Santini; Cristina Mosconi; Nicole Brighi; Laura Alberici; Francesco Minni; Riccardo Casadei
Journal:  Endocrine       Date:  2019-02-22       Impact factor: 3.633

6.  Recent standardization of treatment strategy for pancreatic neuroendocrine tumors.

Authors:  Masayuki Imamura
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

7.  Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.

Authors:  Tetsuhide Ito; Hironobu Sasano; Masao Tanaka; R Yoshiyuki Osamura; Iwao Sasaki; Wataru Kimura; Koji Takano; Takao Obara; Miyuki Ishibashi; Kazuwa Nakao; Ryuichiro Doi; Akira Shimatsu; Toshirou Nishida; Izumi Komoto; Yukio Hirata; Kazuhiko Nakamura; Hisato Igarashi; Robert T Jensen; Bertram Wiedenmann; Masayuki Imamura
Journal:  J Gastroenterol       Date:  2010-02       Impact factor: 7.527

8.  Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany.

Authors:  Hans Scherübl; Brigitte Streller; Roland Stabenow; Hermann Herbst; Michael Höpfner; Christoph Schwertner; Joachim Steinberg; Jan Eick; Wanda Ring; Krishna Tiwari; Sören M Zappe
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 9.  Prognostic factors in gastrointestinal endocrine tumors.

Authors:  Guido Rindi; Tiziana D'Adda; Elisabetta Froio; Giovanni Fellegara; Cesare Bordi
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

10.  Diagnosis and prediction of neuroendocrine liver metastases: a protocol of six systematic reviews.

Authors:  Stephan Arigoni; Stefan Ignjatovic; Patrizia Sager; Jonas Betschart; Tobias Buerge; Josephine Wachtl; Christoph Tschuor; Perparim Limani; Milo A Puhan; Mickael Lesurtel; Dimitri A Raptis; Stefan Breitenstein
Journal:  JMIR Res Protoc       Date:  2013-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.